DGA S.A. Logo

DGA S.A.

Consulting, training, and EU-funded project services for public and private organizations.

DGA | WAR

Overview

Corporate Details

ISIN(s):
PLDGA0000019 (+1 more)
LEI:
259400DTDT4GWZLEL890
Country:
Poland
Address:
Poznań Towarowa 37, 61-896 Poznań
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DGA S.A. is a consulting and advisory group with over 35 years of experience in providing innovative solutions and professional guidance. The company's core activities include business and management consulting, corporate restructuring advisory, and the implementation of comprehensive training programs for both individuals and organizations. DGA specializes in acquiring and executing projects co-financed by external sources, including European Union funds. The firm actively fosters innovation through incubation and acceleration programs for startups and social initiatives. Its diverse service portfolio also covers labor market activation, educational development programs, and specialized coaching. DGA serves a broad clientele, ranging from micro to large enterprises, public institutions, and non-governmental organizations.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 17:08
Management Discussion and Analysis
Informacje dodatkowe i komentarz Zarządu do informacji finansowych
Polish 1.5 MB
2025-11-28 17:08
Quarterly Report
Sprawozdanie finansowe DGA S.A. za III kw. 2025 r.
Polish 2.0 MB
2025-11-17 09:18
Environmental & Social Information
Podpisanie aneksu do umowy o dofinansowanie projektu DGA S.A. - Content (PL)
Polish 1.2 KB
2025-10-13 14:22
Environmental & Social Information
Wybór projektu DGA S.A. do dofinansowania - Content (PL)
Polish 1.2 KB
2025-09-30 17:17
Interim Report
Oświadczenie Zarządu
Polish 1.0 MB
2025-09-30 17:17
Audit Report / Information
Raport z przeglądu sprawozdania finansowego DGA S.A.
Polish 411.5 KB
2025-09-30 17:17
Management Discussion and Analysis
Sprawozdanie Zarządu z działalności DGA S.A. za I półrocze 2025 r
Polish 1.5 MB
2025-09-30 17:17
Annual / Quarterly Financial Statement
Sprawozdanie finansowe DGA S.A. za I półrocze 2025 r.
Polish 1.8 MB
2025-07-31 14:15
Regulatory News Service
Zawiadomienie o zejściu poniżej progu 5% ogólnej liczby głosów w Spółce - Conte…
Polish 1.8 KB
2025-07-30 15:04
Major Shareholding Notification
Zawiadomienie akcjonariusza
Polish 78.4 KB
2025-07-30 15:04
Major Shareholding Notification
Zawiadomienie o przekroczeniu progu 5% ogólnej liczby głosów w Spółce - Content…
Polish 1.2 KB
2025-07-29 13:56
Regulatory News Service
Otrzymanie podpisanego egzemplarza umowy znaczącej - Content (PL)
Polish 475 bytes
2025-07-17 15:22
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
Polish 1.3 KB
2025-05-29 17:26
Management Discussion and Analysis
Informacje uzupełniające i komentarz Zarządu
Polish 1.5 MB
2025-05-29 17:26
Quarterly Report
Jednostkowe sprawozdanie finansowe DGA S.A. za I kw. 2025 r.
Polish 1.7 MB

Automate Your Workflow. Get a real-time feed of all DGA S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DGA S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DGA S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Material Group inc. Logo
A professional services firm offering PR consulting, marketing, and brand strategy.
Japan
156A
Medesis Pharma S.A. Logo
Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.
France
ALMDP
Medicofarma Biotech Spolka Akcyjna Logo
A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.
Poland
MDB
Medpace Holdings, Inc. Logo
Global CRO providing full-service clinical development to biotech, pharma & medical device industries.
United States of America
MEDP
Develops biomarker-based precision therapies for oncology and other incurable diseases.
South Korea
235980
Medrx Co.,Ltd. Logo
Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.
Japan
4586
Developing nanomedicines and drug delivery systems for oncology, hematology, and diagnostics.
Malaysia
N/A
A holding company driving regional growth by supporting construction, HR, and nursing care businesses.
Japan
7369
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden
IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America
M3D

Talk to a Data Expert

Have a question? We'll get back to you promptly.